French translation of: Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS trial

Smith, Matthew R.; Hussain, Maha; Saad, Fred; Fizazi, Karim; Sternberg, Cora N.; Crawford, David; Manarite, Jan; Muslin, David; Farrington, Thomas; Tombal, Bertrand

doi:10.25402/FON.22188283.v3

French QR.pdf (2.25 MB)

French translation of: Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS trial

journal contribution

posted on 2023-03-15, 12:48 authored by Matthew R. Smith, Maha Hussain, Fred Saad, Karim Fizazi, Cora N. Sternberg, David Crawford, Jan Manarite, David Muslin, Thomas Farrington, Bertrand Tombal

French translation

History

Usage metrics

Keywords

urological/prostate safety plain language summary overall survival novel therapy metastatic hormone-sensitive prostate cancer lay summary drug development darolutamide

Licence

CC BY-NC-ND 4.0

French translation of: Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS trial

History

Usage metrics

Categories

Keywords

Licence

Exports